United Therapeutics Corp.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $1.57B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $505.9M | 32.3% |
| Stock Repurchases | $1.00B | 63.8% |
| Other Financing | $55.3M | 3.5% |
| Working Capital | $6.8M | 0.4% |
| Net Cash Flow | $0 | 0.0% |